FADS2 converts them into arachidonic acid and, interestingly, palmitate can compete with linoleic and alpha-linoleic acids in this reaction [45], which could explain the ability of FADS2 to compensate for the lack of SCD activity in cancer cells [42]. The gene discussed is SCD; the disease is cancer.